Arrow-right Camera

The Spokesman-Review Newspaper The Spokesman-Review

Wednesday, August 21, 2019  Spokane, Washington  Est. May 19, 1883
Cloudy 67° Cloudy

Health

News >  Health

Washington hospital addresses mold infections in patients

UPDATED: Thu., Aug. 15, 2019, 6:13 p.m.

The Seattle Children’s Hospital has avoided federal punishment after fixing the cause of mold infections in its patients. The Seattle Times reported that the Centers for Medicare and Medicaid Services announced it will not terminate its program agreement after the hospital upgraded its air-filtration system attributed to mold infections in patients earlier this year. Health officials say 14 operating rooms were closed after Aspergillus mold sickened more than five patients.

News >  Health

Gym bag magic: How to pack for going from workout to work

What are essentials to pack in a gym bag if you’re going from an early morning workout, then directly to work, or maybe to a lunchtime workout? Fitness fans pack smart the night before and keep a small bag of travel toiletries. Baby wipes and dry shampoos are popular, too.
News >  Health

Hospital visits up during wildfires in Clark County

UPDATED: Wed., July 3, 2019, 9:56 p.m.

As the climate changes and wildfires are becoming more frequent, data and studies are starting to demonstrate how wildfire smoke can have adverse health effects, even for those who are miles away from the fire.
News >  Health

Spokane clinic gives patients with neurological diseases options to join clinical trials

UPDATED: Thu., June 27, 2019, 7:04 a.m.

Since 2018, a Spokane biomedical research company has waded into multiple clinical trials to find treatments to slow or more effectively fight neurological conditions such as Parkinson’s disease. With more than 100 participants so far, the studies are at Inland Northwest Research, owned by neurologist Dr. Jason Aldred, and also looking at Huntington’s disease, Lou Gehrig’s disease and multiple sclerosis.
News >  Health

FDA approves $2M medicine, most expensive ever

UPDATED: Fri., May 24, 2019, 6:09 p.m.

U.S. regulators have approved the most expensive medicine ever, a $2.125 million gene therapy meant to cure a disorder that rapidly destroys a baby’s muscle control and kills most within a couple years.